SciSparc (SPRC) Cash & Equivalents (2016 - 2025)

SciSparc has reported Cash & Equivalents for 10 years, with the latest figure at $4.6 million in Q4 2025.

• Quarterly Cash & Equivalents rose 198.12% year-over-year to $4.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.6 million (up 198.12% YoY) and the FY2025 annual result came in at $4.6 million, up 198.12% from the prior year.
• Cash & Equivalents climbed to $4.6 million in Q4 2025 per SPRC's latest filing, from $1.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $12.9 million in Q2 2022 and troughed at $252000.0 in Q2 2024.
• A 5-year average of $4.6 million and a median of $3.6 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2021 and 2024: Cash & Equivalents surged 5170.83% in 2021, then plunged 87.89% in 2024.
• Over 5 years, Cash & Equivalents stood at $6.9 million in 2021, then slumped by 48.01% to $3.6 million in 2022, then plunged by 41.91% to $2.1 million in 2023, then dropped by 25.82% to $1.5 million in 2024, then jumped by 198.12% to $4.6 million in 2025.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $4.6 million, $1.5 million, and $1.5 million for Q4 2025, Q2 2025, and Q4 2024 respectively.